Technological advancements are revolutionizing the healthcare industry all around the globe. China, South Korea and India with their huge population and healthcare challenges are emerging as biotech clusters with many notable startups in the region. New entrepreneurship communities have also emerged in Malaysia and Indonesia. Not far behind, Singapore and Taiwan have been investing heavily to carve their niche in this industry by encouraging entrepreneurs and developing their local talent pool. In the recent times, a large number of artificial intelligence (AI) and machine learning (ML) relying startups have emerged in these countries and cancer is one condition few startups are putting their bets on.